5-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
申请人:——
公开号:US20040242868A1
公开(公告)日:2004-12-02
Compounds of formula (I):
1
or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
5'-ACYLAMINO-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS
申请人:GLAXO GROUP LIMITED
公开号:EP1435934A1
公开(公告)日:2004-07-14
US7432289B2
申请人:——
公开号:US7432289B2
公开(公告)日:2008-10-07
[EN] 5'-ACYLAMINO-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS<br/>[FR] DERIVES DE 5'-ACYLAMINO-1,1'-BIPHENYL-4-CARBOXAMIDE ET LEUR UTILISATION COMME INHIBITEURS DE LA KINASE P 38
申请人:GLAXO GROUP LTD
公开号:WO2003032971A1
公开(公告)日:2003-04-24
Compounds of formula (I): wherein R3 is the group -NH-CO-R6; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
申请人:Glaxo Group Limited
公开号:US07432289B2
公开(公告)日:2008-10-07
Compounds of formula (I):
or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.